KPCD_RAT - dbPTM
KPCD_RAT - PTM Information in dbPTM
Basic Information of Protein
UniProt ID KPCD_RAT
UniProt AC P09215
Protein Name Protein kinase C delta type
Gene Name Prkcd
Organism Rattus norvegicus (Rat).
Sequence Length 673
Subcellular Localization Cytoplasm . Nucleus . Cytoplasm, perinuclear region . Membrane
Peripheral membrane protein .
Protein Description Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti-apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression, is required for oxygen radical production by NADPH oxidase and acts as positive or negative regulator in platelet functional responses. Upon DNA damage, activates the promoter of the death-promoting transcription factor BCLAF1/Btf to trigger BCLAF1-mediated p53/TP53 gene transcription and apoptosis. In response to oxidative stress, interact with and activate CHUK/IKKA in the nucleus, causing the phosphorylation of p53/TP53. In the case of ER stress or DNA damage-induced apoptosis, can form a complex with the tyrosine-protein kinase ABL1 which trigger apoptosis independently of p53/TP53. In cytosol can trigger apoptosis by activating MAPK11 or MAPK14, inhibiting AKT1 and decreasing the level of X-linked inhibitor of apoptosis protein (XIAP), whereas in nucleus induces apoptosis via the activation of MAPK8 or MAPK9. Upon ionizing radiation treatment, is required for the activation of the apoptosis regulators BAX and BAK, which trigger the mitochondrial cell death pathway. Can phosphorylate MCL1 and target it for degradation which is sufficient to trigger for BAX activation and apoptosis. Is required for the control of cell cycle progression both at G1/S and G2/M phases. Mediates phorbol 12-myristate 13-acetate (PMA)-induced inhibition of cell cycle progression at G1/S phase by up-regulating the CDK inhibitor CDKN1A/p21 and inhibiting the cyclin CCNA2 promoter activity. In response to UV irradiation can phosphorylate CDK1, which is important for the G2/M DNA damage checkpoint activation. Can protect glioma cells from the apoptosis induced by TNFSF10/TRAIL, probably by inducing increased phosphorylation and subsequent activation of AKT1. Can also act as tumor suppressor upon mitogenic stimulation with PMA or TPA. In N-formyl-methionyl-leucyl-phenylalanine (fMLP)-treated cells, is required for NCF1 (p47-phox) phosphorylation and activation of NADPH oxidase activity, and regulates TNF-elicited superoxide anion production in neutrophils, by direct phosphorylation and activation of NCF1 or indirectly through MAPK1/3 (ERK1/2) signaling pathways. May also play a role in the regulation of NADPH oxidase activity in eosinophil after stimulation with IL5, leukotriene B4 or PMA. In collagen-induced platelet aggregation, acts a negative regulator of filopodia formation and actin polymerization by interacting with and negatively regulating VASP phosphorylation. Downstream of PAR1, PAR4 and CD36/GP4 receptors, regulates differentially platelet dense granule secretion; acts as a positive regulator in PAR-mediated granule secretion, whereas it negatively regulates CD36/GP4-mediated granule release. Phosphorylates MUC1 in the C-terminal and regulates the interaction between MUC1 and beta-catenin (By similarity). The catalytic subunit phosphorylates 14-3-3 proteins (YWHAB, YWHAZ and YWHAH) in a sphingosine-dependent fashion. Phosphorylates ELAVL1 in response to angiotensin-2 treatment (By similarity).; Truncated isoform 2 is inactive..
Protein Sequence MAPFLRISFNSYELGSLQAEDDASQPFCAVKMKEALTTDRGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEDPMSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMCVQYFLEDGDCKQSMRSEEEAMFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKEFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTATNSRDTIFQKERFNIDMPHRFKVYNYMSPTFCDHCGTLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQKASRKPETPETVGIYQGFEKKTAVSGNDIPDNNGTYGKIWEGSNRCRLENFTFQKVLGKGSFGKVLLAELKGKERYFAIKYLKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLICTFQTKDHLFFVMEFLNGGDLMFHIQDKGRFELYRATFYAAEIICGLQFLHGKGIIYRDLKLDNVMLDKDGHIKIADFGMCKENIFGENRASTFCGTPDYIAPEILQGLKYSFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDIMEKLFERDPAKRLGVTGNIRLHPFFKTINWNLLEKRKVEPPFKPKVKSPSDYSNFDPEFLNEKPQLSFSDKNLIDSMDQTAFKGFSFVNPKYEQFLE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
37PhosphorylationVKMKEALTTDRGKTL
EEHHHHHHCCCCCCH
33.4323984901
38PhosphorylationKMKEALTTDRGKTLV
EHHHHHHCCCCCCHH
25.2523984901
43PhosphorylationLTTDRGKTLVQKKPT
HHCCCCCCHHCCCCC
34.6823984901
50PhosphorylationTLVQKKPTMYPEWKS
CHHCCCCCCCCCHHH
37.91-
64PhosphorylationSTFDAHIYEGRVIQI
HCEEEEEECCCEEEE
11.4917562707
130PhosphorylationEDGDCKQSMRSEEEA
HCCCHHHHHCCHHHH
11.1422108457
141PhosphorylationEEEAMFPTMNRRGAI
HHHHHCCCCCCCCHH
18.80-
155PhosphorylationIKQAKIHYIKNHEFI
HHHHEEEEEECCCEE
19.6417562707
164PhosphorylationKNHEFIATFFGQPTF
ECCCEEHHHHCCCCH
18.06-
211PhosphorylationIIGRCTGTATNSRDT
HHHHCCCCCCCCCCC
16.5023984901
213PhosphorylationGRCTGTATNSRDTIF
HHCCCCCCCCCCCCC
33.3023984901
215PhosphorylationCTGTATNSRDTIFQK
CCCCCCCCCCCCCEE
27.4623984901
218PhosphorylationTATNSRDTIFQKERF
CCCCCCCCCCEEHHC
23.6822673903
295O-linked_GlycosylationAEALNQVTQKASRKP
HHHHHHHHHHHHCCC
18.0018295358
295PhosphorylationAEALNQVTQKASRKP
HHHHHHHHHHHHCCC
18.0023984901
297UbiquitinationALNQVTQKASRKPET
HHHHHHHHHHCCCCC
38.68-
299PhosphorylationNQVTQKASRKPETPE
HHHHHHHHCCCCCCC
48.12-
304PhosphorylationKASRKPETPETVGIY
HHHCCCCCCCCCEEE
34.6528432305
307PhosphorylationRKPETPETVGIYQGF
CCCCCCCCCEEECCC
25.8228432305
311PhosphorylationTPETVGIYQGFEKKT
CCCCCEEECCCEECC
9.1719161989
331PhosphorylationDIPDNNGTYGKIWEG
CCCCCCCCCCCCCCC
31.0922276854
332PhosphorylationIPDNNGTYGKIWEGS
CCCCCCCCCCCCCCC
20.1617569658
348O-linked_GlycosylationRCRLENFTFQKVLGK
CEEEECEEEEEECCC
36.4212639201
357PhosphorylationQKVLGKGSFGKVLLA
EEECCCCCCHHHHHH
34.0218295358
357O-linked_GlycosylationQKVLGKGSFGKVLLA
EEECCCCCCHHHHHH
34.0218295358
372PhosphorylationELKGKERYFAIKYLK
HHCCCHHEEEEEHHC
9.8410319993
449PhosphorylationRFELYRATFYAAEII
CEEEHHHHHHHHHHH
14.26-
504PhosphorylationIFGENRASTFCGTPD
CCCCCCCHHCCCCCC
20.8423991683
505PhosphorylationFGENRASTFCGTPDY
CCCCCCHHCCCCCCC
23.2023991683
509PhosphorylationRASTFCGTPDYIAPE
CCHHCCCCCCCCCHH
17.7327097102
512PhosphorylationTFCGTPDYIAPEILQ
HCCCCCCCCCHHHHC
10.5327097102
523PhosphorylationEILQGLKYSFSVDWW
HHHCCCCCEEECCHH
21.719326592
565PhosphorylationIRVDTPHYPRWITKE
HCCCCCCCCCCCCHH
8.8310319993
592O-linked_GlycosylationPAKRLGVTGNIRLHP
HHHHHCCCCCEEECH
23.78182109
603PhosphorylationRLHPFFKTINWNLLE
EECHHHCCCCHHHHH
17.8723984901
628PhosphorylationKVKSPSDYSNFDPEF
CCCCHHHHCCCCHHH
15.1710319993
629PhosphorylationVKSPSDYSNFDPEFL
CCCHHHHCCCCHHHH
35.6925575281
643PhosphorylationLNEKPQLSFSDKNLI
HCCCCCCCCCCCCHH
19.9123712012
645PhosphorylationEKPQLSFSDKNLIDS
CCCCCCCCCCCHHHH
44.2827097102
652PhosphorylationSDKNLIDSMDQTAFK
CCCCHHHHCCHHHHC
19.7723984901
656PhosphorylationLIDSMDQTAFKGFSF
HHHHCCHHHHCCCCC
29.7825575281
662PhosphorylationQTAFKGFSFVNPKYE
HHHHCCCCCCCHHHH
36.6323991683

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
64YPhosphorylationKinaseSRCP12931
PSP
155YPhosphorylationKinaseABL1P00519
GPS
311YPhosphorylationKinaseSRCP12931
PSP
311YPhosphorylationKinaseSRC64-PhosphoELM
311YPhosphorylationKinaseSRCQ9WUD9
Uniprot
311YPhosphorylationKinaseLCKP06240
PSP
311YPhosphorylationKinaseEGFRP00533
PSP
332YPhosphorylationKinaseSRCP12931
PSP
332YPhosphorylationKinaseEGFRP00533
PSP
332YPhosphorylationKinaseSRCQ9WUD9
Uniprot
372YPhosphorylationKinaseSRCP12931
PSP
505TPhosphorylationKinasePRKCEP16054
GPS
505TPhosphorylationKinasePDPK1O15530
GPS
505TPhosphorylationKinasePDK1O55173
GPS
505TPhosphorylationKinasePRKCDP09215
GPS
565YPhosphorylationKinaseSRCP12931
PSP
628YPhosphorylationKinaseSRCP12931
PSP
662SPhosphorylationKinasePRKCDP09215
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
299SPhosphorylation

18550549
505TPhosphorylation

9677322
505TPhosphorylation

9677322

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of KPCD_RAT !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HMGB1_RATHmgb1physical
10617144
UBC_RATUbcphysical
9447980
H11_RATHist1h1aphysical
11118818

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of KPCD_RAT

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS.";
Moser K., White F.M.;
J. Proteome Res. 5:98-104(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-662, AND MASSSPECTROMETRY.
"Tyrosine phosphorylation modifies protein kinase C delta-dependentphosphorylation of cardiac troponin I.";
Sumandea M.P., Rybin V.O., Hinken A.C., Wang C., Kobayashi T.,Harleton E., Sievert G., Balke C.W., Feinmark S.J., Solaro R.J.,Steinberg S.F.;
J. Biol. Chem. 283:22680-22689(2008).
Cited for: PHOSPHORYLATION AT TYR-311; TYR-332 AND THR-505.
"Protein kinase Cepsilon (PKCepsilon) and Src control PKCdeltaactivation loop phosphorylation in cardiomyocytes.";
Rybin V.O., Guo J., Gertsberg Z., Elouardighi H., Steinberg S.F.;
J. Biol. Chem. 282:23631-23638(2007).
Cited for: PHOSPHORYLATION AT THR-505.
"The broad specificity of dominant inhibitory protein kinase C mutantsinfers a common step in phosphorylation.";
Garcia-Paramio P., Cabrerizo Y., Bornancin F., Parker P.J.;
Biochem. J. 333:631-636(1998).
Cited for: MUTAGENESIS OF THR-505, AND PHOSPHORYLATION AT THR-505.
"Induction of apoptosis is driven by nuclear retention of proteinkinase C delta.";
DeVries-Seimon T.A., Ohm A.M., Humphries M.J., Reyland M.E.;
J. Biol. Chem. 282:22307-22314(2007).
Cited for: SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT TYR-64 AND TYR-155.

TOP